Shares of Ardent Health Partners, LLC (NYSE:ARDT – Get Free Report) have been given an average recommendation of “Buy” by the thirteen research firms that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $20.75.
ARDT has been the subject of several recent analyst reports. Mizuho reduced their target price on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday, April 9th. Guggenheim upped their target price on shares of Ardent Health Partners from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, May 9th. Royal Bank of Canada reiterated an “outperform” rating and issued a $21.00 target price on shares of Ardent Health Partners in a research note on Thursday. Morgan Stanley cut their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Finally, Stephens reissued an “overweight” rating and issued a $22.00 price target on shares of Ardent Health Partners in a report on Tuesday, April 1st.
Check Out Our Latest Research Report on ARDT
Ardent Health Partners Trading Up 1.1%
Ardent Health Partners (NYSE:ARDT – Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.08. The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.50 billion. As a group, research analysts predict that Ardent Health Partners will post 1.23 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Ardent Health Partners
Several institutional investors have recently added to or reduced their stakes in the business. Ventas Inc. purchased a new stake in Ardent Health Partners during the fourth quarter valued at about $159,570,000. Point72 Asset Management L.P. lifted its holdings in Ardent Health Partners by 7.9% during the fourth quarter. Point72 Asset Management L.P. now owns 1,609,720 shares of the company’s stock valued at $27,494,000 after purchasing an additional 117,421 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Ardent Health Partners by 368.9% during the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock valued at $18,296,000 after purchasing an additional 1,046,845 shares during the last quarter. Franklin Resources Inc. lifted its holdings in Ardent Health Partners by 9.4% during the fourth quarter. Franklin Resources Inc. now owns 917,926 shares of the company’s stock valued at $15,678,000 after purchasing an additional 78,575 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Ardent Health Partners by 4.8% during the first quarter. Allspring Global Investments Holdings LLC now owns 817,182 shares of the company’s stock valued at $10,599,000 after purchasing an additional 37,581 shares during the last quarter.
Ardent Health Partners Company Profile
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Featured Stories
- Five stocks we like better than Ardent Health Partners
- What is the Nasdaq? Complete Overview with History
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- How to Profit From Value Investing
- Savvy Investors Are Raising a Glass for Heineken Stock
- Growth Stocks: What They Are, Examples and How to Invest
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.